Latest Insider Transactions at Dia Medica Therapeutics Inc. (DMAC)
This section provides a real-time view of insider transactions for Dia Medica Therapeutics Inc. (DMAC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DiaMedica Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DiaMedica Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 01
2021
|
James T. Parsons Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,745
+26.08%
|
$61,960
$8.23 P/Share
|
|
Jan 01
2021
|
Randall Michael Giuffre Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,441
+6.03%
|
$59,528
$8.23 P/Share
|
|
Dec 04
2020
|
Richard D. Pilnik Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.82%
|
$50,000
$5.37 P/Share
|
|
Nov 20
2020
|
Randall Michael Giuffre Director |
BUY
Open market or private purchase
|
Direct |
15,000
+12.14%
|
$60,000
$4.26 P/Share
|
|
Nov 09
2020
|
Scott Kellen CFO and Secretary |
BUY
Open market or private purchase
|
Direct |
2,000
+14.0%
|
$8,000
$4.19 P/Share
|